Anglia Capital Group backs Norwich-based Virilitas Labs with a £100k investment.
"The founders demonstrated a strong grasp of the clinical and commercial needs in this space. Their technology addresses an important issue that resonates strongly with our investors, who are committed to backing impactful innovation. We’re thrilled to welcome Virilitas Labs into the ACG portfolio and support their next stage of growth."
Surface Ventures led the pre-seed round to support product development and team expansion.
"The assumption that bigger is always better needs to go. Specialized SLMs routinely outperform frontier models at role-specific tasks—with greater efficiency and reliability. We’re building the infrastructure and developer tooling to bring those benefits to the enterprise."